HIV post-exposure prophylaxis can be given upto –
**Question:** HIV post-exposure prophylaxis can be given up to -
A. 72 hours
B. 48 hours
C. 24 hours
D. 12 hours
**Core Concept:** HIV post-exposure prophylaxis refers to the use of antiretroviral medications given within 72 hours following potential exposure to human immunodeficiency virus (HIV) to reduce the risk of acquiring HIV infection. This therapy aims to prevent the establishment of HIV infection by inhibiting viral entry, replication, and integration into the host cell.
**Why the Correct Answer is Right:**
Choice B (48 hours) is incorrect because the standard antiretroviral prophylaxis regimen includes a combination of three drugs: Tenofovir, Emtricitabine, and Raltegravir. These drugs should be taken within 72 hours to maximize their effectiveness in blocking HIV replication and preventing viral entry into host cells.
Choice C (24 hours) is also incorrect because this timeframe is shorter than the recommended duration for antiretroviral prophylaxis. The therapy is most effective when initiated within the first 72 hours after exposure, allowing sufficient time for the drugs to reach optimal concentrations within the body and inhibit HIV replication.
Choice D (12 hours) is too short for effective antiretroviral prophylaxis. HIV infection depends on the duration of exposure, the amount of virus, and the effectiveness of the antiretroviral therapy. Antiretroviral prophylaxis requires time for drug absorption, distribution, and attainment of therapeutic levels. In this scenario, the correct answer is A (72 hours), as it provides sufficient time for the drugs to reach optimal concentrations and inhibit HIV replication, leading to a higher likelihood of preventing HIV infection.
**Why Each Wrong Option is Incorrect:**
Option A (72 hours) is correct as it allows for sufficient time for the antiretroviral medications to be absorbed, distributed, and reach therapeutic levels within the body. This helps to inhibit HIV replication and minimize the risk of HIV infection.
Option B (48 hours) is incorrect because this duration is shorter than the recommended timeframe for antiretroviral prophylaxis. The therapy must be initiated within the first 72 hours to ensure optimal drug concentrations and effective inhibition of HIV replication.
Option C (24 hours) is too short for effective antiretroviral prophylaxis. Antiretroviral therapy requires time to achieve therapeutic levels, which is not possible within 24 hours.
Option D (12 hours) is too short for the drugs to reach optimal concentrations and inhibit HIV replication. Antiretroviral therapy requires time for absorption, distribution, and attainment of therapeutic levels within the body.
**Clinical Pearls:**
1. HIV post-exposure prophylaxis should be initiated within 72 hours of potential HIV exposure to maximize the chances of preventing HIV infection.
2. The therapy relies on achieving therapeutic drug concentrations within the body, which is not possible within the short timeframes provided in options B, C